jardiance vs semaglutide vs. Januvia for Type 2 Diabetes Jardiance (empagliflozin) - MedicalMex

NICE guidance (NG28) on type 2 diabetes management includes GLP-1 receptor agonists like Ozempic as treatment options, and efforts should be made to support patients through the initial side effect period when clinically appropriate

Another emerging pillar of neuroprotection involves NIBS, particularly tDCS and repetitive transcranial magnetic stimulation (rTMS)

These include orlistat, liraglutide, and semaglutide (NICE TA875 for weight management in adults with obesity), as well as GLP-1 receptor agonists within the framework of NICE NG28 (type 2 diabetes management)

These diabetes-specific results mirror the pattern seen with CagriSema in REDEFINE 2, though direct comparison requires caution because the trial populations and designs differed

Yet these same pathways create problems elsewhere